Michael Jameson

11PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOther information and computing sciences not elsewhere classifiedMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2026
Exploration of Safety, Pharmacokinetics and Selected Pharmacodynamic Mechanisms of High-Dose Se-Methylselenocysteine, L-Selenomethionine and Selenite in a Phase Ib Trial in Cancer Patients.

|Jun 21, 2023
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022.

Ankit Jain, Kirsten L Gormly, Tamara Glyn

|Oct 20, 2022
Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer.

Frank Po-Yen Lin, Osama S M Salih, Nina Scott

|Mar 24, 2022
TNT: Raising more questions than answers?

Michael B Jameson, Andrew R L Stevenson, Samuel Y Ngan

|Dec 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.

Ezra E W Cohen, Lisle Nabell, Deborah J Wong

|Nov 27, 2021
Remote Skin Cancer Diagnosis: Adding Images to Electronic Referrals Is More Efficient Than Wait-Listing for a Nurse-Led Imaging Clinic.

Leah Jones, Michael Jameson, Amanda Oakley

Pageof 2

Frequent Collaborators

1 joint publications

Navin T Wewala

1 joint publications

Richard J Lobb

1 joint publications

Jonathan S Cebon

1 joint publications

Catriona M McNeil